1
Clinical Trials associated with GSK-4024484A Phase 1, Randomised, Double Blind Placebo-controlled, First Time in Human Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Oral Doses and Food Effect of GSK4024484 in Healthy Adult Participants.
The primary purpose of the study is to characterise the safety of GSK4024484 in healthy participants within a controlled pharmacokinetic (PK) range.
100 Clinical Results associated with GSK-4024484
100 Translational Medicine associated with GSK-4024484
100 Patents (Medical) associated with GSK-4024484
100 Deals associated with GSK-4024484